Trial Profile
Influenza immunity: protective mechanisms against a pandemic respiratory virus.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine live (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 12 May 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 05 Dec 2005 New trial record.